Colleran David

Insider profile

Performance

Overall performance
1.7

Performance over holding periods
1.7
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Colleran David's trades of Anika Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
490.51
Quantity 62,150 +39.4%
Value US$1,276,834
Transaction date
Planned sale
Price
263.33
Quantity 38,269 +2.1%
Value US$2,546,603
Transaction date
Sale
Price
94.65
Quantity 20,975 -40.8%
Value US$1,985,359
Transaction date
Planned sale
Price
80.72
Quantity 6,834 -16.7%
Value US$551,640
Transaction date
Planned sale
Price
80.00
Quantity 4,826 -12.4%
Value US$386,080
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-05-12 2022-05-11 B Purchase
62,150 +39.4%
490.51
US$1,276,834
62,150 +39.4% 490.51 US$1,276,834
2022-03-16 2022-03-14 B Purchase
42,760 -1.4%
180.34
US$3,159,816
42,760 -1.4% 180.34 US$3,159,816
2019-04-04 2019-04-02 PlS Planned sale
38,269 +2.1%
263.33
US$2,546,603
38,269 +2.1% 263.33 US$2,546,603
2019-03-05 2019-03-01 S Sale
20,975 -40.8%
94.65
US$1,985,359
20,975 -40.8% 94.65 US$1,985,359
2019-02-06 2019-02-05 PlS Planned sale
6,834 -16.7%
80.72
US$551,640
6,834 -16.7% 80.72 US$551,640
2019-02-01 2019-01-31 PlS Planned sale
4,826 -12.4%
80.00
US$386,080
4,826 -12.4% 80.00 US$386,080